Zevra Therapeutics, Inc. ZVRA Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Zevra Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s earnings yield?
- Zevra Therapeutics, Inc. (ZVRA) reported earnings yield of 22.7% in Q1 2026.
- How has Zevra Therapeutics, Inc.'s earnings yield changed year-over-year?
- Zevra Therapeutics, Inc.'s earnings yield increased by 200.0% year-over-year, from -22.7% to 22.7%.
- What is the long-term trend for Zevra Therapeutics, Inc.'s earnings yield?
- Over 4 years (2020 to 2025), Zevra Therapeutics, Inc.'s earnings yield has grown at a -10.5% compound annual growth rate (CAGR), from -25.7% to 16.5%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.